SUMF2 Inhibitors
SUMF2 (Sulfatase Modifying Factor 2) inhibitors are not well-characterized in terms of direct chemical entities. However, understanding the indirect inhibition of SUMF2 can be approached by considering the role of SUMF2 in the post-translational modification of sulfatases and its interaction with cellular pathways. SUMF2 is involved in the maturation and stability of sulfatase enzymes, which are crucial for the hydrolysis of sulfate esters, a significant step in the metabolism of sulfate conjugates, including glycosaminoglycans and steroid sulfates. The chemicals listed, although not direct inhibitors of SUMF2, can impact its function or expression by altering cellular environments or signaling pathways. For instance, agents like Chloroquine and Bafilomycin A1 affect lysosomal pH, a critical factor in sulfatase modification and maturation. Since SUMF2 is involved in this process, altering lysosomal acidity can indirectly influence SUMF2's role. Similarly, proteasome inhibitors like MG-132 [Z-Leu- Leu-Leu-CHO] could affect the turnover of SUMF2 or its related proteins, thereby impacting its functional efficiency.
Moreover, inhibitors of key signaling pathways (such as mTOR, PI3K, MEK, MAPK, JNK, and Hsp90) can indirectly influence SUMF2. These pathways are integral to various cellular processes, including protein synthesis, stability, and degradation. Inhibiting these pathways can lead to altered expression levels or the functional dynamics of SUMF2. For instance, Hsp90 inhibitors like 17-AAG could affect the stability of proteins that interact with SUMF2, thus indirectly influencing SUMF2's role in sulfatase maturation. In summary, while direct SUMF2 inhibitors are not well-documented, understanding the indirect inhibition of this protein involves a comprehensive look at various cellular processes and signaling pathways that can influence its activity and expression. The impact on SUMF2 through these indirect means can be crucial for research in areas where modulation of sulfatase activity is desired.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Chloroquine | 54-05-7 | sc-507304 | 250 mg | $69.00 | 2 | |
Chloroquine, primarily an antimalarial, is known to alter lysosomal pH, potentially affecting SUMF2-related sulfatase modification and activation. | ||||||
Bafilomycin A1 | 88899-55-2 | sc-201550 sc-201550A sc-201550B sc-201550C | 100 µg 1 mg 5 mg 10 mg | $98.00 $255.00 $765.00 $1457.00 | 280 | |
This compound is a specific inhibitor of the V-ATPase proton pump, impacting lysosomal acidification, which could indirectly influence SUMF2 functions. | ||||||
Cycloheximide | 66-81-9 | sc-3508B sc-3508 sc-3508A | 100 mg 1 g 5 g | $41.00 $84.00 $275.00 | 127 | |
Cycloheximide inhibits protein synthesis in eukaryotic organisms, potentially affecting the synthesis of SUMF2 and its associated proteins. | ||||||
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | $60.00 $265.00 $1000.00 | 163 | |
MG-132 [Z-Leu- Leu-Leu-CHO] is a proteasome inhibitor that can impact protein degradation pathways, potentially influencing the turnover of SUMF2 or related sulfatases. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin inhibits mTOR, a key regulator of cell growth and proliferation, which could indirectly affect SUMF2 expression or function. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
This is a PI3K inhibitor, potentially altering signaling pathways that could indirectly modulate SUMF2 activity or stability. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
This p38 MAPK inhibitor might affect signaling pathways related to SUMF2 function or expression. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
As a PI3K inhibitor like LY 294002, Wortmannin could indirectly affect SUMF2 through modulation of PI3K/Akt signaling. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD 98059 is an inhibitor of MEK, which, like U0126, could affect pathways relevant to SUMF2 activity. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
This is a JNK inhibitor, potentially affecting signaling pathways that indirectly influence SUMF2. | ||||||